
ANG Lifesciences India Ltd is Rated Strong Sell
2026-05-13 10:10:31ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Jun 2023. However, the analysis and financial metrics discussed here reflect the company’s current position as of 13 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read More
ANG Lifesciences India Ltd is Rated Strong Sell
2026-04-28 10:10:21ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Jun 2023. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.
Read More
ANG Lifesciences India Ltd is Rated Strong Sell
2026-04-16 10:10:16ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2023. However, the analysis and financial metrics discussed below reflect the company’s current position as of 16 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
05-Jun-2026 | Source : BSENewspaper Publication of Audited Financial Results for the quarter and year ended March 31 2026.
Results - 31.03.2026
30-May-2026 | Source : BSEAudited Results 31.03.2026
Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended 31St March 2026
30-May-2026 | Source : BSEAudited Financial Results for the quarter and year ended 31st March 2026
Corporate Actions
No Upcoming Board Meetings
ANG Lifesciences India Ltd has declared 10% dividend, ex-date: 02 Nov 21
No Splits history available
ANG Lifesciences India Ltd has announced 1:4 bonus issue, ex-date: 13 Jul 22
No Rights history available
